SEC 13F Intelligence

M.d. Sass, LLC / CHE

M.d. Sass, LLC’s Chemed Corp New Position

Does M.d. Sass, LLC own Chemed Corp New (CHE)? Not currently — the last reported position was 51.1K shares worth $33M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$33M
Q1 2024
Shares
51.1K
% of Portfolio
+3.70%
Quarters Held
10
position exited

Position History CHE

Reported value by quarter
Q4 ’21: $16MQ4 ’21Q1 ’22: $21MQ2 ’22: $26MQ2 ’22Q3 ’22: $26MQ4 ’22: $31MQ4 ’22Q1 ’23: $31MQ2 ’23: $32MQ2 ’23Q3 ’23: $35MQ4 ’23: $33MQ4 ’23Q1 ’24: $33Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202451.1K$33M+3.70%
Q4 202357.0K$33M+4.01%
Q3 202367.3K$35M+4.70%
Q2 202358.3K$32M+4.19%
Q1 202356.8K$31M+3.80%
Q4 202261.4K$31M+4.60%
Q3 202258.8K$26M+4.71%
Q2 202255.5K$26M+4.93%
Q1 202241.0K$21M+3.56%
Q4 202129.4K$16M+2.42%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See M.d. Sass, LLC’s full portfolio or all institutional holders of CHE.